How to Dispose of Controlled Substances
How DEA registrants and consumers must destroy Schedule I to V drugs so they are rendered non-retrievable, and how to reconcile DEA destruction with EPA hazardous-waste rules.
What counts as controlled substances
Scope covers all DEA-controlled substances in Schedules I to V: prescription opioids, benzodiazepines, stimulants, barbiturates, and similar regulated drugs held by healthcare generators or consumers. The governing standard is non-retrievable: under 21 CFR 1300.05 a controlled substance must be rendered, through a process that permanently and irreversibly alters its physical or chemical state, unavailable and unusable for all practical purposes so it cannot be transformed back into the substance or a controlled-substance analogue. This is why a controlled substance may not simply be dropped in a red bag, regular trash, or a standard pharmaceutical waste bin unless that pathway actually meets the non-retrievable standard.
Two disposal tracks exist. DEA registrants (pharmacies, hospitals, clinics, practitioners, distributors) follow 21 CFR Part 1317 Subpart A. Ultimate users (consumers, household members, and persons settling a decedent's estate) follow Subpart B, which the Secure and Responsible Drug Disposal Act of 2010 created to give the public secure, voluntary disposal options. Consumers are not required to render the drugs non-retrievable themselves; they hand the substances to an authorized collector or law enforcement, who carry the non-retrievable destruction obligation.
Step by step: containment, segregation, transport
- Confirm the drug is a DEA-controlled substance and identify your track.
Determine whether the drug is in Schedule I to V (opioids, benzodiazepines, stimulants, barbiturates, and the like). If you are a DEA registrant (pharmacy, hospital, clinic, practitioner, distributor), you are on the registrant track under 21 CFR Part 1317 Subpart A. If you are a consumer or settling an estate, you are an ultimate user on the Subpart B track. Non-controlled drugs follow ordinary pharmaceutical-waste rules and are not covered here.
- Registrants: choose an authorized destruction or transfer pathway.
Under 21 CFR 1317.05, a registrant may only: (1) promptly destroy the substance on-site under Subpart C; (2) promptly deliver it to a reverse distributor's registered location; or (3) return or deliver it for recall to the registered supplier, the manufacturer, or another authorized registrant. A practitioner may also request DEA assistance via DEA Form 41. Whatever the method, destruction must achieve the non-retrievable standard.
- Consumers: use take-back events, mail-back, or a collection receptacle.
Under the Secure and Responsible Drug Disposal Act of 2010 and 21 CFR Part 1317 Subpart B, consumers have three voluntary options: deposit Schedule II to V drugs in a collection receptacle (drop box) at an authorized collector such as a retail pharmacy or hospital or clinic with an on-site pharmacy; use a mail-back package; or bring drugs to a periodic take-back event run by DEA or law enforcement. Long-term care facilities may dispose of residents' controlled substances on the resident's behalf.
- Screen for dual waste (controlled AND RCRA-hazardous).
Some controlled substances are also RCRA hazardous waste (dual waste), for example phenobarbital and certain fentanyl products. Identify these before disposal, because they trigger an added EPA condition. They may not be sewered and may not be managed under the simpler non-controlled hazardous-waste pathway alone.
- For dual waste, satisfy both DEA and EPA with permitted incineration.
Under 40 CFR 266.506, a dual-waste pharmaceutical is conditionally exempt from RCRA only if it is not sewered, is managed in compliance with DEA regulations, and is either destroyed by a method DEA has publicly deemed in writing to meet the non-retrievable standard or combusted at a specified permitted facility (a municipal waste combustor, a hospital, medical, or infectious waste incinerator, a commercial and industrial solid waste incinerator, or a hazardous waste combustor). Because DEA has not publicly recognized a non-incineration method as non-retrievable, incineration at a permitted facility is the practical pathway that satisfies both agencies at once.
Container, color code, and labeling
The controlling rule is the non-retrievable standard at 21 CFR 1300.05: a controlled substance must be rendered, through an irreversible process, permanently unusable and incapable of being transformed back into the substance or an analogue. DEA sets the result, not a single mandated method. Registrants execute this through the authorized pathways at 21 CFR 1317.05 (on-site destruction under Subpart C, prompt delivery to a registered reverse distributor, or return or recall to the supplier or manufacturer); reverse distributors then destroy or return the material under their registration. The compliance tension arises when a drug is both DEA-controlled and RCRA-hazardous. DEA wants it destroyed (historically only incineration has met non-retrievable), while RCRA governs hazardous-waste pharmaceuticals separately, and the two regimes can conflict. EPA resolves this in 40 CFR 266.506: a dual-waste pharmaceutical is conditionally exempt from RCRA if it is not sewered, is managed per DEA rules, and is destroyed by a DEA-recognized non-retrievable method or combusted at a specified permitted facility. RCRA-permitted incineration is the single action that satisfies both DEA non-retrievable destruction and EPA hazardous-waste compliance.
Frequently asked questions
Can I throw controlled substances in the red bag, regular trash, or a standard pharma waste bin?
No, not unless that pathway actually renders the drug non-retrievable. 21 CFR 1300.05 requires controlled substances to be permanently and irreversibly altered so they are unusable and cannot be reconstituted. A red bag, ordinary trash, or a routine pharmaceutical waste container does not by itself meet that standard, and sewer disposal is also prohibited for dual-waste drugs under 40 CFR 266.506.
What does non-retrievable actually mean?
Per 21 CFR 1300.05, non-retrievable is the condition to which a controlled substance is rendered after a process that permanently alters its physical or chemical state through irreversible means, making it unavailable and unusable for all practical purposes and impossible to transform back into the controlled substance or an analogue. DEA specifies the outcome rather than one required method.
How are consumers supposed to dispose of leftover prescriptions?
The Secure and Responsible Drug Disposal Act of 2010 gives consumers three voluntary options: a collection receptacle (drop box) at an authorized collector such as a retail pharmacy or hospital or clinic pharmacy; a mail-back package; or a DEA or law-enforcement take-back event. Consumers do not have to destroy the drugs themselves; the authorized collector handles non-retrievable destruction.
What is the dual-waste problem and how is it solved?
Some drugs are both DEA-controlled and RCRA-hazardous (for example phenobarbital and certain fentanyl products). DEA requires non-retrievable destruction while EPA regulates the same item as hazardous waste, which can conflict. 40 CFR 266.506 resolves it: the drug is conditionally exempt from RCRA if it is not sewered, is managed per DEA rules, and is incinerated at a specified permitted facility (or destroyed by a DEA-recognized non-retrievable method). Permitted incineration satisfies both agencies.